{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "toc_visible": true,
      "authorship_tag": "ABX9TyMwfxloGPBxmtKFSu2igv5Y",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/preranareddy08/b192082/blob/main/Assignment1.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "hjj9z0e8S3Ip",
        "outputId": "e603a577-6df5-48fd-a3c3-29f784fd15a8"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting vaderSentiment\n",
            "  Downloading vaderSentiment-3.3.2-py2.py3-none-any.whl.metadata (572 bytes)\n",
            "Requirement already satisfied: requests in /usr/local/lib/python3.10/dist-packages (from vaderSentiment) (2.32.3)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests->vaderSentiment) (3.4.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests->vaderSentiment) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests->vaderSentiment) (2.2.3)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests->vaderSentiment) (2024.8.30)\n",
            "Downloading vaderSentiment-3.3.2-py2.py3-none-any.whl (125 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m126.0/126.0 kB\u001b[0m \u001b[31m2.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: vaderSentiment\n",
            "Successfully installed vaderSentiment-3.3.2\n"
          ]
        }
      ],
      "source": [
        "!pip install vaderSentiment\n",
        "\n",
        "# Step 1: Import Libraries\n",
        "import pandas as pd\n",
        "import spacy\n",
        "from vaderSentiment.vaderSentiment import SentimentIntensityAnalyzer\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Step 2: Load Data\n",
        "# Replace these paths with your actual file paths\n",
        "media_data = pd.read_excel(\"/content/Media & Research Articles data.xlsx\")\n",
        "twitter_data = pd.read_excel(\"/content/Twitter Posts Data.xlsx\")\n",
        "\n"
      ],
      "metadata": {
        "id": "vCVFpB2MTe2V"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Step 3: Explore and Clean Data\n",
        "# Adding a 'Source' column to track data origin\n",
        "media_data['Source'] = 'Media'\n",
        "twitter_data['Source'] = 'Twitter'\n",
        "\n"
      ],
      "metadata": {
        "id": "vg0OoMMjTtJq"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Renaming columns for consistency\n",
        "media_data = media_data.rename(columns={\n",
        "    'Article title': 'Title',\n",
        "    'Content': 'Body'\n",
        "})\n"
      ],
      "metadata": {
        "id": "6Z7ZlSdXTvad"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "twitter_data = twitter_data.rename(columns={\n",
        "    'Posts': 'Title',\n",
        "    'replied_to_tweet': 'Body'\n",
        "})\n",
        "\n"
      ],
      "metadata": {
        "id": "kw5CqDgwTy7D"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Step 4: Merge Datasets Vertically\n",
        "# Concatenate datasets\n",
        "combined_data = pd.concat([media_data, twitter_data], ignore_index=True)\n",
        "\n"
      ],
      "metadata": {
        "id": "OspPeYu-T2eD"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Step 5: Create a 'Combined' Column\n",
        "# Combine the 'Title' and 'Body' into a single column for analysis\n",
        "combined_data['Combined'] = combined_data['Title'].fillna('') + \" \" + combined_data['Body'].fillna('')\n"
      ],
      "metadata": {
        "id": "ThtPMnY9T5fI"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Step 6: Load spaCy Model and VADER Sentiment Analyzer\n",
        "nlp = spacy.load(\"en_core_web_sm\")\n",
        "vader = SentimentIntensityAnalyzer()\n",
        "\n"
      ],
      "metadata": {
        "id": "xCKmRkwnT8JH"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Function to Extract Entities\n",
        "def extract_entities(text):\n",
        "    doc = nlp(text)\n",
        "    entities = [(ent.text, ent.label_) for ent in doc.ents]\n",
        "    return entities\n",
        "\n"
      ],
      "metadata": {
        "id": "5yhzNms3UABc"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Function to Perform Sentiment Analysis\n",
        "def analyze_sentiment(text):\n",
        "    sentiment = vader.polarity_scores(text)\n",
        "    if sentiment['compound'] >= 0.05:\n",
        "        return 'Positive'\n",
        "    elif sentiment['compound'] <= -0.05:\n",
        "        return 'Negative'\n",
        "    else:\n",
        "        return 'Neutral'"
      ],
      "metadata": {
        "id": "RgSGWZY8UCeh"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Function for Topic Classification (using keyword-based approach)\n",
        "def classify_topic(text):\n",
        "    text = text.lower()\n",
        "    if \"efficacy\" in text or \"effective\" in text:\n",
        "        return \"Efficacy-General\"\n",
        "    elif \"progression free survival\" in text or \"pfs\" in text:\n",
        "        return \"Progression Free Survival (PFS)\"\n",
        "    elif \"overall survival\" in text or \"os\" in text:\n",
        "        return \"Overall Survival (OS)\"\n",
        "    elif \"safety\" in text and \"side effects\" in text:\n",
        "        return \"Safety-Side Effects\"\n",
        "    elif \"safety\" in text:\n",
        "        return \"Safety-General\"\n",
        "    elif \"opinion\" in text or \"thoughts\" in text:\n",
        "        return \"General Opinion\"\n",
        "    else:\n",
        "        return \"Others\"\n"
      ],
      "metadata": {
        "id": "8OUnpqjbURLe"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Step 7: Apply NLP Analysis\n",
        "combined_data['Entities'] = combined_data['Combined'].apply(extract_entities)\n",
        "combined_data['Topic'] = combined_data['Combined'].apply(classify_topic)\n",
        "combined_data['Sentiment'] = combined_data['Combined'].apply(analyze_sentiment)\n",
        "\n"
      ],
      "metadata": {
        "id": "oDuZyPJhUUjR"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Step 8: Save Output to CSV\n",
        "combined_data.to_csv(\"predictions_without_openai.csv\", index=False)\n"
      ],
      "metadata": {
        "id": "QKmAVDghUsGg"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Displaying the first few rows of the final DataFrame\n",
        "print(combined_data.head())\n",
        "\n",
        "nlp = spacy.load(\"en_core_web_sm\")\n",
        "vader = SentimentIntensityAnalyzer()\n",
        "\n",
        "def extract_entities(text):\n",
        "    doc = nlp(text)\n",
        "    entities = [(ent.text, ent.label_) for ent in doc.ents]\n",
        "    return entities\n",
        "def analyze_sentiment(text):\n",
        "    sentiment = vader.polarity_scores(text)\n",
        "    if sentiment['compound'] >= 0.05:\n",
        "        return 'Positive'\n",
        "    elif sentiment['compound'] <= -0.05:\n",
        "        return 'Negative'\n",
        "    else:\n",
        "        return 'Neutral'\n",
        "def classify_topic(text):\n",
        "    text = text.lower()\n",
        "    if \"efficacy\" in text or \"effective\" in text:\n",
        "        return \"Efficacy-General\"\n",
        "    elif \"progression free survival\" in text or \"pfs\" in text:\n",
        "        return \"Progression Free Survival (PFS)\"\n",
        "    elif \"overall survival\" in text or \"os\" in text:\n",
        "        return \"Overall Survival (OS)\"\n",
        "    elif \"safety\" in text and \"side effects\" in text:\n",
        "        return \"Safety-Side Effects\"\n",
        "    elif \"safety\" in text:\n",
        "        return \"Safety-General\"\n",
        "    elif \"opinion\" in text or \"thoughts\" in text:\n",
        "        return \"General Opinion\"\n",
        "    else:\n",
        "        return \"Others\"\n",
        "\n",
        "combined_data['Entities'] = combined_data['Combined'].apply(extract_entities)\n",
        "combined_data['Topic'] = combined_data['Combined'].apply(classify_topic)\n",
        "combined_data['Sentiment'] = combined_data['Combined'].apply(analyze_sentiment)\n",
        "\n",
        "combined_data.to_csv(\"predictions_without_openai.csv\", index=False)\n",
        "\n",
        "combined_data.head()\n",
        "\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "bUOy7cKKUvtG",
        "outputId": "bc86865d-530a-47a6-ab7e-b926650b6097"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "                  unique_id  \\\n",
            "0       Ascopost_51_Q2_2024   \n",
            "1      Ascopost_267_Q2_2024   \n",
            "2  CancerNetwork_90_Q2_2024   \n",
            "3       MedScape_50_Q2_2024   \n",
            "4       MedScape_98_Q2_2024   \n",
            "\n",
            "                                               Title  \\\n",
            "0   USPSTF Issues Final Recommendation Statement ...   \n",
            "1   Dennis J. Slamon, MD, PhD, Awarded 2024 Szent...   \n",
            "2  Nivolumab Combo Significantly Boosts Survival ...   \n",
            "3  No Improvement in OS With Atezolizumab in Earl...   \n",
            "4  ADCs for Breast Cancer: Clear Benefits, Manage...   \n",
            "\n",
            "                                                Body         Source  \\\n",
            "0  On April 30, 2024, the U.S. Preventive Service...       Ascopost   \n",
            "1  The National Foundation for Cancer Research (N...       Ascopost   \n",
            "2  Findings from the CheckMate-901 study support ...  CancerNetwork   \n",
            "3  Adding atezolizumab to chemotherapy in patient...       MedScape   \n",
            "4  Antibody drug conjugates (ADCs) — a class of t...       MedScape   \n",
            "\n",
            "     Source Type                                       Article link  \\\n",
            "0  Media Sources  https://ascopost.com/issues/may-25-2024/uspstf...   \n",
            "1  Media Sources  https://ascopost.com/news/june-2024/dennis-sla...   \n",
            "2  Media Sources  https://www.cancernetwork.com/view/nivolumab-c...   \n",
            "3  Media Sources  https://www.medscape.com/viewarticle/no-improv...   \n",
            "4  Media Sources  https://www.medscape.com/viewarticle/adcs-brea...   \n",
            "\n",
            "  Published date HCP Handle Post link  \\\n",
            "0     2024-05-25        NaN       NaN   \n",
            "1     2024-06-05        NaN       NaN   \n",
            "2     2024-05-08        NaN       NaN   \n",
            "3     2024-05-16        NaN       NaN   \n",
            "4     2024-05-21        NaN       NaN   \n",
            "\n",
            "                                            Combined  \\\n",
            "0   USPSTF Issues Final Recommendation Statement ...   \n",
            "1   Dennis J. Slamon, MD, PhD, Awarded 2024 Szent...   \n",
            "2  Nivolumab Combo Significantly Boosts Survival ...   \n",
            "3  No Improvement in OS With Atezolizumab in Earl...   \n",
            "4  ADCs for Breast Cancer: Clear Benefits, Manage...   \n",
            "\n",
            "                                            Entities  \\\n",
            "0  [(April 30, 2024, DATE), (the U.S. Preventive ...   \n",
            "1  [(Dennis J. Slamon, PERSON), (MD, GPE), (PhD, ...   \n",
            "2  [(Nivolumab Combo Significantly Boosts Surviva...   \n",
            "3  [(12 months, DATE), (first, ORDINAL), (Rebecca...   \n",
            "4  [(Breast Cancer, PERSON), (Manageable Risks An...   \n",
            "\n",
            "                             Topic Sentiment  \n",
            "0                 Efficacy-General  Negative  \n",
            "1            Overall Survival (OS)  Negative  \n",
            "2  Progression Free Survival (PFS)  Positive  \n",
            "3            Overall Survival (OS)  Positive  \n",
            "4                 Efficacy-General  Negative  \n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                  unique_id  \\\n",
              "0       Ascopost_51_Q2_2024   \n",
              "1      Ascopost_267_Q2_2024   \n",
              "2  CancerNetwork_90_Q2_2024   \n",
              "3       MedScape_50_Q2_2024   \n",
              "4       MedScape_98_Q2_2024   \n",
              "\n",
              "                                               Title  \\\n",
              "0   USPSTF Issues Final Recommendation Statement ...   \n",
              "1   Dennis J. Slamon, MD, PhD, Awarded 2024 Szent...   \n",
              "2  Nivolumab Combo Significantly Boosts Survival ...   \n",
              "3  No Improvement in OS With Atezolizumab in Earl...   \n",
              "4  ADCs for Breast Cancer: Clear Benefits, Manage...   \n",
              "\n",
              "                                                Body         Source  \\\n",
              "0  On April 30, 2024, the U.S. Preventive Service...       Ascopost   \n",
              "1  The National Foundation for Cancer Research (N...       Ascopost   \n",
              "2  Findings from the CheckMate-901 study support ...  CancerNetwork   \n",
              "3  Adding atezolizumab to chemotherapy in patient...       MedScape   \n",
              "4  Antibody drug conjugates (ADCs) — a class of t...       MedScape   \n",
              "\n",
              "     Source Type                                       Article link  \\\n",
              "0  Media Sources  https://ascopost.com/issues/may-25-2024/uspstf...   \n",
              "1  Media Sources  https://ascopost.com/news/june-2024/dennis-sla...   \n",
              "2  Media Sources  https://www.cancernetwork.com/view/nivolumab-c...   \n",
              "3  Media Sources  https://www.medscape.com/viewarticle/no-improv...   \n",
              "4  Media Sources  https://www.medscape.com/viewarticle/adcs-brea...   \n",
              "\n",
              "  Published date HCP Handle Post link  \\\n",
              "0     2024-05-25        NaN       NaN   \n",
              "1     2024-06-05        NaN       NaN   \n",
              "2     2024-05-08        NaN       NaN   \n",
              "3     2024-05-16        NaN       NaN   \n",
              "4     2024-05-21        NaN       NaN   \n",
              "\n",
              "                                            Combined  \\\n",
              "0   USPSTF Issues Final Recommendation Statement ...   \n",
              "1   Dennis J. Slamon, MD, PhD, Awarded 2024 Szent...   \n",
              "2  Nivolumab Combo Significantly Boosts Survival ...   \n",
              "3  No Improvement in OS With Atezolizumab in Earl...   \n",
              "4  ADCs for Breast Cancer: Clear Benefits, Manage...   \n",
              "\n",
              "                                            Entities  \\\n",
              "0  [(April 30, 2024, DATE), (the U.S. Preventive ...   \n",
              "1  [(Dennis J. Slamon, PERSON), (MD, GPE), (PhD, ...   \n",
              "2  [(Nivolumab Combo Significantly Boosts Surviva...   \n",
              "3  [(12 months, DATE), (first, ORDINAL), (Rebecca...   \n",
              "4  [(Breast Cancer, PERSON), (Manageable Risks An...   \n",
              "\n",
              "                             Topic Sentiment  \n",
              "0                 Efficacy-General  Negative  \n",
              "1            Overall Survival (OS)  Negative  \n",
              "2  Progression Free Survival (PFS)  Positive  \n",
              "3            Overall Survival (OS)  Positive  \n",
              "4                 Efficacy-General  Negative  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-d5bb7950-4469-4d05-a495-3f0b40cc11d4\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>unique_id</th>\n",
              "      <th>Title</th>\n",
              "      <th>Body</th>\n",
              "      <th>Source</th>\n",
              "      <th>Source Type</th>\n",
              "      <th>Article link</th>\n",
              "      <th>Published date</th>\n",
              "      <th>HCP Handle</th>\n",
              "      <th>Post link</th>\n",
              "      <th>Combined</th>\n",
              "      <th>Entities</th>\n",
              "      <th>Topic</th>\n",
              "      <th>Sentiment</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Ascopost_51_Q2_2024</td>\n",
              "      <td>USPSTF Issues Final Recommendation Statement ...</td>\n",
              "      <td>On April 30, 2024, the U.S. Preventive Service...</td>\n",
              "      <td>Ascopost</td>\n",
              "      <td>Media Sources</td>\n",
              "      <td>https://ascopost.com/issues/may-25-2024/uspstf...</td>\n",
              "      <td>2024-05-25</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>USPSTF Issues Final Recommendation Statement ...</td>\n",
              "      <td>[(April 30, 2024, DATE), (the U.S. Preventive ...</td>\n",
              "      <td>Efficacy-General</td>\n",
              "      <td>Negative</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Ascopost_267_Q2_2024</td>\n",
              "      <td>Dennis J. Slamon, MD, PhD, Awarded 2024 Szent...</td>\n",
              "      <td>The National Foundation for Cancer Research (N...</td>\n",
              "      <td>Ascopost</td>\n",
              "      <td>Media Sources</td>\n",
              "      <td>https://ascopost.com/news/june-2024/dennis-sla...</td>\n",
              "      <td>2024-06-05</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Dennis J. Slamon, MD, PhD, Awarded 2024 Szent...</td>\n",
              "      <td>[(Dennis J. Slamon, PERSON), (MD, GPE), (PhD, ...</td>\n",
              "      <td>Overall Survival (OS)</td>\n",
              "      <td>Negative</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>CancerNetwork_90_Q2_2024</td>\n",
              "      <td>Nivolumab Combo Significantly Boosts Survival ...</td>\n",
              "      <td>Findings from the CheckMate-901 study support ...</td>\n",
              "      <td>CancerNetwork</td>\n",
              "      <td>Media Sources</td>\n",
              "      <td>https://www.cancernetwork.com/view/nivolumab-c...</td>\n",
              "      <td>2024-05-08</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Nivolumab Combo Significantly Boosts Survival ...</td>\n",
              "      <td>[(Nivolumab Combo Significantly Boosts Surviva...</td>\n",
              "      <td>Progression Free Survival (PFS)</td>\n",
              "      <td>Positive</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>MedScape_50_Q2_2024</td>\n",
              "      <td>No Improvement in OS With Atezolizumab in Earl...</td>\n",
              "      <td>Adding atezolizumab to chemotherapy in patient...</td>\n",
              "      <td>MedScape</td>\n",
              "      <td>Media Sources</td>\n",
              "      <td>https://www.medscape.com/viewarticle/no-improv...</td>\n",
              "      <td>2024-05-16</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>No Improvement in OS With Atezolizumab in Earl...</td>\n",
              "      <td>[(12 months, DATE), (first, ORDINAL), (Rebecca...</td>\n",
              "      <td>Overall Survival (OS)</td>\n",
              "      <td>Positive</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>MedScape_98_Q2_2024</td>\n",
              "      <td>ADCs for Breast Cancer: Clear Benefits, Manage...</td>\n",
              "      <td>Antibody drug conjugates (ADCs) — a class of t...</td>\n",
              "      <td>MedScape</td>\n",
              "      <td>Media Sources</td>\n",
              "      <td>https://www.medscape.com/viewarticle/adcs-brea...</td>\n",
              "      <td>2024-05-21</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>ADCs for Breast Cancer: Clear Benefits, Manage...</td>\n",
              "      <td>[(Breast Cancer, PERSON), (Manageable Risks An...</td>\n",
              "      <td>Efficacy-General</td>\n",
              "      <td>Negative</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-d5bb7950-4469-4d05-a495-3f0b40cc11d4')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-d5bb7950-4469-4d05-a495-3f0b40cc11d4 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-d5bb7950-4469-4d05-a495-3f0b40cc11d4');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-9b6d68fa-92fb-40ab-9bb8-125ec09decc2\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-9b6d68fa-92fb-40ab-9bb8-125ec09decc2')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-9b6d68fa-92fb-40ab-9bb8-125ec09decc2 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "combined_data",
              "summary": "{\n  \"name\": \"combined_data\",\n  \"rows\": 100,\n  \"fields\": [\n    {\n      \"column\": \"unique_id\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 100,\n        \"samples\": [\n          \"Twitter_19312_Q2_2024_Non-KI\",\n          \"Twitter_2968_Q2_2024\",\n          \"Twitter_9100_Q2_2024_Non-KI\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Title\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 97,\n        \"samples\": [\n          \"@KrishanJethwa \\ud83e\\udd14Hard to reconcile with NRG GI 002. Could neoadjuvant chemo before CRT/IO have a detrimental effect?\",\n          \"A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation.\",\n          \"@SuyogCancer @VPrasadMDMPH Difference might be trial design , cross over etc \\nWill have to look at details \\n\\nIf progression while on Opdivo - I would do Platinum + Gem or EV alone \\n\\nIf progression &gt; 6 months post Opdivo than EV/ Pembro\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Body\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 98,\n        \"samples\": [\n          \"Congratulations @hoperugo! So well deserved https://t.co/z8PnhrTqdS\",\n          \"Purpose:Real-time intrafraction tracking/gating is an integral component of magnetic resonance imaging-guided radiation therapy (MRgRT) and may have contributed to the acute toxicity reduction during prostate stereotactic body radiation therapy observed on the MRgRT-arm of the MIRAGE (MAGNETIC RESONANCE IMAGING-GUIDED Stereotactic Body Radiotherapy for Prostate Cancer) randomized trial (NCT04384770). Herein we characterized intrafraction prostate motion and assessed gating effectiveness.Methods and materials:Seventy-nine patients were treated on an MR-LINAC. Real-time cine imaging was acquired at 4Hz in a sagittal plane. If >10% of the prostate area moved outside of a 3-mm gating boundary, an automatic beam hold was initiated. An in-house tool was developed to retrospectively extract gating signal for all patients and identify the tracked prostate in each cine frame for a subgroup of 40 patients. The fraction of time the prostate was within the gating window was defined as the gating duty cycle (GDC).Results:A total of 391 treatments from 79 patients were analyzed. Median GDC was 0.974 (IQR, 0.916-0.983). Fifty (63.2%) and 24 (30.4%) patients had at least 1 fraction with GDC \\u22640.9 and GDC \\u22640.8, respectively. Incidence of low GDC fractions among patients appeared stochastic. Patients with minimum GDC <0.8 trended toward more frequent grade 2 genitourinary toxicity compared with those with minimum GDC >0.8 (38% vs 18%, P = .065). Prostate intrafraction motion was mostly along the bladder-rectum axis and predominantly in the superior-anterior direction. Motion in the inferior-posterior direction was associated with significantly higher rate of acute grade 2 genitourinary toxicity (66.7% vs 13.9%, P = .001). Gating limited mean prostate motion during treatment delivery in fractions with a GDC <0.9 (<0.8) to 2.9 mm (2.9 mm) versus 4.1 mm (4.7 mm) for ungated motion.Conclusions:Fractions with large intrafraction motion were associated with increased toxicity and their occurrence among patients appears stochastic. Real-time tracking/gating effectively mitigated this motion and is likely a major contributing factor of acute toxicity reduction associated with MRgRT.\",\n          \"Adjuvant Nivolumab finally shows OS benifit in MIUC . Checkmate274 . #EAU24 . adjuvant Pembrolizumab did not in Ambassador . Again why one IO works and other does not ? I don't know  . Any one ? What to give these pts on progression  after adjuvant  Nivo ?  @VPrasadMDMPH\\u2026 https://t.co/kNRDH9oOh6 https://t.co/XJi3a7muYM\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Source\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 11,\n        \"samples\": [\n          \"Urology Today\",\n          \"Ascopost\",\n          \"Semantic Scholar\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Source Type\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"Media Sources\",\n          \"Research Articles\",\n          \"Social Media\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Article link\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 48,\n        \"samples\": [\n          \"https://www.urotoday.com//conference-highlights/aua-2024/aua-2024-bladder-cancer/151890-aua-2024-optimal-turbt-do-skilled-urologists-really-need-to-perform-retur-for-all-hg-patients.html\",\n          \"https://pubmed.ncbi.nlm.nih.gov/38160916/\",\n          \"https://www.urotoday.com//video-lectures/asco-2024/video-2/mediaitem/4133-brca2-and-beyond-unraveling-genetic-drivers-of-prostate-cancer-aggressiveness-hiba-khan.html\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Published date\",\n      \"properties\": {\n        \"dtype\": \"date\",\n        \"min\": \"2022-06-01 00:00:00\",\n        \"max\": \"2024-06-29 00:00:00\",\n        \"num_unique_values\": 52,\n        \"samples\": [\n          \"2024-04-09 00:00:00\",\n          \"2024-05-24 00:00:00\",\n          \"2024-06-06 00:00:00\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"HCP Handle\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 39,\n        \"samples\": [\n          \"LauraBukavinaMD\",\n          \"breastsurgNYC\",\n          \"StoverLab\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Post link\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"https://twitter.com/drsarahsam/status/1784228904212840800\",\n          \"https://twitter.com/Dr_Oncologista/status/1804279203547807838\",\n          \"https://twitter.com/OncBrothers/status/1783153145645838414\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Combined\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 98,\n        \"samples\": [\n          \"@StoverLab @hoperugo Truly a breast cancer legend Congratulations @hoperugo! So well deserved https://t.co/z8PnhrTqdS\",\n          \"Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized Trial. Purpose:Real-time intrafraction tracking/gating is an integral component of magnetic resonance imaging-guided radiation therapy (MRgRT) and may have contributed to the acute toxicity reduction during prostate stereotactic body radiation therapy observed on the MRgRT-arm of the MIRAGE (MAGNETIC RESONANCE IMAGING-GUIDED Stereotactic Body Radiotherapy for Prostate Cancer) randomized trial (NCT04384770). Herein we characterized intrafraction prostate motion and assessed gating effectiveness.Methods and materials:Seventy-nine patients were treated on an MR-LINAC. Real-time cine imaging was acquired at 4Hz in a sagittal plane. If >10% of the prostate area moved outside of a 3-mm gating boundary, an automatic beam hold was initiated. An in-house tool was developed to retrospectively extract gating signal for all patients and identify the tracked prostate in each cine frame for a subgroup of 40 patients. The fraction of time the prostate was within the gating window was defined as the gating duty cycle (GDC).Results:A total of 391 treatments from 79 patients were analyzed. Median GDC was 0.974 (IQR, 0.916-0.983). Fifty (63.2%) and 24 (30.4%) patients had at least 1 fraction with GDC \\u22640.9 and GDC \\u22640.8, respectively. Incidence of low GDC fractions among patients appeared stochastic. Patients with minimum GDC <0.8 trended toward more frequent grade 2 genitourinary toxicity compared with those with minimum GDC >0.8 (38% vs 18%, P = .065). Prostate intrafraction motion was mostly along the bladder-rectum axis and predominantly in the superior-anterior direction. Motion in the inferior-posterior direction was associated with significantly higher rate of acute grade 2 genitourinary toxicity (66.7% vs 13.9%, P = .001). Gating limited mean prostate motion during treatment delivery in fractions with a GDC <0.9 (<0.8) to 2.9 mm (2.9 mm) versus 4.1 mm (4.7 mm) for ungated motion.Conclusions:Fractions with large intrafraction motion were associated with increased toxicity and their occurrence among patients appears stochastic. Real-time tracking/gating effectively mitigated this motion and is likely a major contributing factor of acute toxicity reduction associated with MRgRT.\",\n          \"@SuyogCancer @VPrasadMDMPH Difference might be trial design , cross over etc \\nWill have to look at details \\n\\nIf progression while on Opdivo - I would do Platinum + Gem or EV alone \\n\\nIf progression &gt; 6 months post Opdivo than EV/ Pembro Adjuvant Nivolumab finally shows OS benifit in MIUC . Checkmate274 . #EAU24 . adjuvant Pembrolizumab did not in Ambassador . Again why one IO works and other does not ? I don't know  . Any one ? What to give these pts on progression  after adjuvant  Nivo ?  @VPrasadMDMPH\\u2026 https://t.co/kNRDH9oOh6 https://t.co/XJi3a7muYM\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Entities\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Topic\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 4,\n        \"samples\": [\n          \"Overall Survival (OS)\",\n          \"Others\",\n          \"Efficacy-General\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Sentiment\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"Negative\",\n          \"Positive\",\n          \"Neutral\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 20
        }
      ]
    },
    {
      "source": [
        "from google.colab import sheets\n",
        "sheet = sheets.InteractiveSheet(df=combined_data)"
      ],
      "cell_type": "code",
      "execution_count": 23,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "https://docs.google.com/spreadsheets/d/1AeIo-fv9G4OTuETPB5GXMXW3Jjoih-yCETTnKOBoHlM#gid=0\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.lib.display.IFrame at 0x7959d3ef0b80>"
            ],
            "text/html": [
              "\n",
              "        <iframe\n",
              "            width=\"100%\"\n",
              "            height=\"600\"\n",
              "            src=\"https://docs.google.com/spreadsheets/d/1AeIo-fv9G4OTuETPB5GXMXW3Jjoih-yCETTnKOBoHlM#gid=0/edit?rm=embedded?usp=sharing?widget=true&amp;headers=false\"\n",
              "            frameborder=\"0\"\n",
              "            allowfullscreen\n",
              "            \n",
              "        ></iframe>\n",
              "        "
            ]
          },
          "metadata": {}
        }
      ],
      "metadata": {
        "cellView": "form",
        "id": "PQ2C9vW5VH1T",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 639
        },
        "outputId": "8ae73772-2c96-4c80-9f3b-bad30526d6f6"
      }
    }
  ]
}